Vertigo relief app

📊 Full opportunity report: Vertigo relief app on IdeaNavigator AI — validation score, market gap, and execution plan.

A new vertigo relief app is in development to assist adults suffering from benign paroxysmal positional vertigo (BPPV) with guided repositioning exercises, symptom logging, and recurrence management. The app aims to address long-standing challenges faced by patients and providers, potentially transforming home care and clinical practice.

The proposed app will be available on iOS and Android platforms, offering step-by-step animated guides, audio cues, and gyroscope-based feedback for maneuvers like the Epley and Brandt-Daroff. It will include a screening tool for BPPV candidacy, episode logging features, and recurrence coaching. The app is designed with a ‘not a substitute for medical advice’ disclaimer and prompts users to consult healthcare providers if red-flag symptoms appear.

Its commercial model includes a freemium subscription for consumers, providing free basic maneuver guides and paid options for advanced features such as detailed symptom tracking, history export, and reminders. Additionally, ENT clinics, audiologists, and vestibular physiotherapists could license the app for patient use outside visits, integrating it into their treatment protocols. For example, clinics might consider using app-based solutions to enhance patient engagement.

The development team plans to validate demand via targeted ads to vertigo-related search terms, measuring signups and user engagement with the maneuver guides. They will also monitor app performance, similar to how DoorDash app outages are tracked. They also intend to pitch clinics on trialing the app with patients, gauging interest and adoption rates.

Potential Impact on Vertigo Self-Management

This app could significantly improve how adults with BPPV manage their condition at home, reducing reliance on long wait times for specialist care and decreasing incorrect self-treatment. By providing guided, real-time feedback and symptom tracking, it aims to lower recurrence rates and improve quality of life for sufferers. Its adoption by clinics could streamline patient care and expand access to effective vestibular therapy outside clinical settings.

Growing Market for Digital Vestibular Therapies

The digital therapeutics market for vestibular disorders was valued near USD 498 million in 2024, with a projected compound annual growth rate of approximately 13.5% through 2033. The COVID-19 pandemic accelerated the shift toward telehealth and home-based rehabilitation, creating a favorable environment for apps like this. Reimbursement policies for digital health solutions are also maturing, increasing potential adoption among healthcare providers and patients.

While guided repositioning exercises are standard treatment for BPPV, many patients struggle to perform maneuvers correctly at home, leading to relapses. Existing solutions often rely on static diagrams or videos, which lack real-time feedback. This app aims to fill that gap with motion sensors and guided instructions, aligning with broader trends in remote vestibular care.

“This app could bridge the gap between clinical treatment and home management, especially for older adults who struggle with self-administered maneuvers.”

— an anonymous researcher

Unanswered Questions About App Validation

It is not yet clear how effective the app will be in real-world settings, as validation studies are still in planning. The actual user engagement, accuracy of gyroscope feedback, and clinical outcomes remain to be demonstrated through trials. Additionally, the level of adoption by clinics and patients is still uncertain, pending initial testing and feedback.

Next Steps for Development and Validation

The development team plans to launch a lightweight landing page with a guided Epley maneuver demo and run targeted advertising campaigns to measure interest and engagement. They will also approach 10-15 ENT and vestibular clinics to pilot the app with patients, collecting feedback on usability and clinical impact. Further validation studies are expected to follow, aiming for broader release upon demonstrating efficacy.

Key Questions

When will the app be available for download?

The app is currently in development, with no confirmed release date. Initial validation and pilot testing are ongoing.

Will the app replace seeing a doctor?

No, the app is designed as a self-management tool and not a substitute for professional medical advice. Users are prompted to consult healthcare providers if red-flag symptoms appear.

How will the app be validated for effectiveness?

Validation will involve user engagement metrics, pilot studies with clinics, and clinical outcome assessments to determine if it reduces vertigo recurrence and improves self-treatment accuracy.

Can clinics white-label the app for their patients?

Yes, the app is intended to be licensed to ENT, audiology, and physiotherapy practices for integration into their patient care programs.

Is this app suitable for all vertigo patients?

The initial focus is on adults with recurrent BPPV, particularly older adults. Other vestibular disorders are not the primary target at this stage.

Source: IdeaNavigator AI